CVJ Stock Chart & Stats
€0.01
<€0.01(8.33%)
At close: 4:00 PM EST
€0.01
<€0.01(8.33%)
Day’s Range― - ―
52-Week Range€0.01 - €0.02
Previous CloseN/A
Volume50.00K
Average Volume (3M)2.37K
Market Cap
€6.21M
Enterprise Value€24.39M
Total Cash (Recent Filing)€490.00K
Total Debt (Recent Filing)€16.84M
Price to Earnings (P/E)0.4
Beta3.40
Next Earnings
Feb 26, 2027EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.02
Shares Outstanding1,660,593,600
10 Day Avg. Volume5,100
30 Day Avg. Volume2,366
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)0.21
Price to Sales (P/S)0.71
P/FCF Ratio-3.51
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Improved Balance SheetThe latest balance sheet is materially more manageable than the prior year, when equity was negative and leverage was distorted. A debt-to-equity ratio of about 0.59 provides a stronger capital base and may improve the company’s ability to sustain operations and pursue recovery.
Lower Cash BurnThe reduction in cash burn is an encouraging operational trend because it indicates some progress toward controlling funding needs. Although Cann Group remains cash-flow negative, continued improvement could extend financial flexibility and reduce the pace at which external capital or balance sheet actions are required.
Positive Net IncomePositive reported net income demonstrates that the company can produce an accounting profit under some conditions, supporting the possibility of eventual earnings recovery. The benefit is tempered because operating margins remained negative, so this result does not yet establish sustainable profitability from the core business.
Bears Say
Declining RevenueA sharp revenue decline indicates weakening commercial traction in the company’s medicinal cannabis operations and reduces the scale available to absorb fixed costs. Unless reversed, sustained contraction can limit operating leverage, make profitability harder to achieve, and increase dependence on financing or restructuring actions.
Persistent Operating LossesConsistently negative EBITDA and EBIT margins show that the core operating model has not yet demonstrated durable economic viability. This weakness limits internally funded investment, leaves the company exposed to further equity deterioration, and makes the recent positive net income less representative of recurring business performance.
Negative Free Cash FlowContinued negative operating and free cash flow means the business is not self-funding its current activities, even after the burn rate improved. Ongoing cash deficits can consume the improved equity cushion and require external funding or balance sheet measures, reducing flexibility over the next several quarters.
Cann Group News
CVJ FAQ
What was Cann Group Ltd.’s price range in the past 12 months?
Cann Group Ltd. lowest stock price was €0.01 and its highest was €0.01 in the past 12 months.
What is Cann Group Ltd.’s market cap?
Cann Group Ltd.’s market cap is €6.21M.
When is Cann Group Ltd.’s upcoming earnings report date?
Cann Group Ltd.’s upcoming earnings report date is Feb 26, 2027 which is in 137 days.
How were Cann Group Ltd.’s earnings last quarter?
Cann Group Ltd. released its earnings results on Aug 31, 2026. The company reported -€0.002 earnings per share for the quarter.
Is Cann Group Ltd. overvalued?
According to Wall Street analysts Cann Group Ltd.’s price is currently Overvalued.
Does Cann Group Ltd. pay dividends?
Cann Group Ltd. does not currently pay dividends.
What is Cann Group Ltd.’s EPS estimate?
Cann Group Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Cann Group Ltd. have?
Cann Group Ltd. has 1,660,593,600 shares outstanding.
What happened to Cann Group Ltd.’s price movement after its last earnings report?
Cann Group Ltd. reported an EPS of -€0.002 in its last earnings report. Following the earnings report the stock price went down -5.882%.
Which hedge fund is a major shareholder of Cann Group Ltd.?
Currently, no hedge funds are holding shares in DE:CVJ
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Cann Group Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Fundamentals
Return on Equity
64.70%
Trailing 12-Months
Asset Growth
-30.23%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Cann Group Ltd.
Cann Group Limited, established in Port Melbourne, Australia, in 2014, specializes in the comprehensive lifecycle of medicinal cannabis. This includes genetic development, cultivation, manufacturing, clinical assessment, and the distribution of therapeutic cannabis products. The company supplies these products for use within Australia and also exports them to international markets, operating under specific licenses that permit research and the cultivation of cannabis for human medicinal and scientific purposes.
Technical Analysis
Elixinol Wellness
―
Little Green Pharma Ltd.
―
Althea Group Holdings Ltd.
―
IDT Australia Limited
―
Cronos Australia Ltd.
―